Skip to main content
PepStack
Blutwerte · Marker

Selen

Selenium · Serum Selenium

Elektrolyte
Einheit:
micro g/L
Abbreviation
Se

Selenium test measures the total concentration of selenium in the blood, reflecting its availability for selenoprotein synthesis.

Reference Ranges

Reference
70–150micro g/L
70
90
120
150
1400
LowNormalHigh
Reference
Optimal
Critical
Unit · micro g/L

Ranges may vary slightly based on dietary intake and regional differences.

Overview

Übersicht

Selenium (Se) is a trace element categorized as an electrolyte and is crucial for the synthesis of selenoproteins, which include selenocysteine. These proteins play significant roles in thyroid hormone metabolism, redox state regulation, and cellular homeostasis. The thyroid gland contains the highest concentration of selenium per gram of tissue in the human body. Clinically, selenium is important in the context of thyroid diseases, cardiovascular health, and immune function. Researchers have found that selenium deficiency is linked to an increased risk of thyroid disorders, such as Hashimoto's thyroiditis and Graves' disease, and may exacerbate conditions following cardiac surgery. For athletes and biohackers, selenium's antioxidant properties are of interest due to its potential to mitigate oxidative stress and inflammation, which can enhance recovery and performance. However, the narrow margin between deficiency and toxicity is a caveat, as excessive selenium can lead to selenosis, characterized by symptoms such as gastrointestinal distress and hair loss. Factors such as dietary intake, environmental exposure, and supplementation can influence selenium levels, and testing should consider these variables.

Klinische Bedeutung

Elevated selenium levels may indicate excessive supplementation or environmental exposure, potentially leading to selenosis. Reduced levels can suggest dietary deficiency, which may increase the risk of thyroid dysfunction and cardiovascular issues.

Dynamics

Trend Interpretation

Rising Values

Progressively rising values may suggest excessive supplementation or exposure; re-test in 4 weeks if levels exceed 150 micro g/L.

Falling Values

Progressively falling values may indicate dietary deficiency or increased physiological demand.

Re-test Interval

4 weeks if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • Excessive supplementation
  • Environmental exposure
  • Diet high in selenium-rich foods
  • Occupational exposure
  • Ingestion of selenium-containing compounds
Cause

Low Levels

  • Poor dietary intake
  • Malabsorption syndromes
  • Gastrointestinal disorders
  • Chronic illness
  • Increased physiological demand
Protocol

How to Optimize

Lever

Lifestyle

  • Regular monitoring of selenium levels
  • Avoidance of high-selenium environments
  • Balanced diet
Lever

Nutrition

  • Brazil nuts
  • Seafood
  • Whole grains
  • Eggs
Lever

Supplementation

  • Selenium yeast
  • Sodium selenite

Note:

Consult a healthcare provider before starting selenium supplements, especially if there is a risk of toxicity.

Testing Guidelines

✓Fasting Not Required
✓Not Time-Sensitive

Testing Frequency

Annually for general health, more frequently if deficiency or toxicity is suspected.

Interfering Factors

  • Recent supplementation
  • Dietary intake
  • Environmental exposure

Related Peptides & Hormones

hormone or peptide

Open Research Questions

Current research suggests that the clinical significance of selenium levels in thyroid disease remains debated, particularly regarding optimal reference ranges and the impact of different selenium forms on toxicity. Researchers have not yet established clear guidelines for selenium supplementation in various conditions, such as thyroid disorders and cardiac surgery. Additionally, unanswered clinical questions include the long-term effects of selenium supplementation and its role in preventing chronic diseases.

50 Research Publications

2,231

Total Citations

12

Human/RCT

2.7

Avg. Influence

2025

Latest

Sort
Filter
#01

Selenium and its supplementation in cardiovascular disease--what do we know?

ReviewInfluence7.0
295
Researchers explored the role of selenium in cardiovascular disease, noting its regulatory functions and the inconclusive results of supplementation studies. They reviewed its potential as a biomarker for heart disease and its significance in surgical contexts.
View on PubMed
#02

Supplementation of Micronutrient Selenium in Metabolic Diseases: Its Role as an Antioxidant.

ReviewInfluence3.0
252
Researchers reviewed the antioxidant role of selenium in chronic metabolic diseases, emphasizing its importance in managing conditions like diabetes and hyperlipidaemia. They discussed the clinical significance of selenium deficiency and the potential benefits of dietary supplementation.
View on PubMed
#03

Adverse health effects of selenium in humans.

ReviewInfluence6.0
249
Researchers highlighted adverse health effects associated with chronic selenium exposure, including endocrine disruption and potential neurotoxicity. They noted that current environmental exposure limits may be insufficient to prevent these health risks.
View on PubMed
#04

Selenium neurotoxicity in humans: bridging laboratory and epidemiologic studies.

ReviewInfluence1.0
185
This study examined selenium neurotoxicity in humans. Researchers found that acute selenium exposure can lead to neurological symptoms, while chronic low-level exposure is associated with an increased risk of conditions like amyotrophic lateral sclerosis. More research is needed to clarify the neurotoxic effects of selenium.
View on PubMed
#05

Evaluating selenium poisoning.

Nuttall Kern L · Annals of clinical and laboratory science · 2006

ReviewInfluence11.0
180
Researchers reviewed selenium poisoning in humans, noting that distinguishing between toxic and non-toxic levels can be challenging due to varying chemical forms of selenium. They reported that acute toxicity is associated with serum levels above 400 micro g/L, while chronic toxicity occurs at levels between 500-1400 micro g/L.

Key findings

  1. 01Researchers found that acute selenium toxicity is often linked to very high serum levels, typically above 1400 micro g/L.
  2. 02They observed that chronic toxicity can occur at lower levels, ranging from 500 to 1400 micro g/L.
  3. 03The study highlighted that different chemical forms of selenium have varying toxic potentials, complicating the assessment of selenium poisoning.
View on PubMed
#06

Microbial reduction and resistance to selenium: Mechanisms, applications and prospects.

ReviewInfluence7.0
137
This study explored microbial reduction of selenium, highlighting its importance in bioremediation and environmental applications. Researchers discussed various microbial pathways for selenium reduction and the potential use of functional genes as biomarkers in different environments.
View on PubMed
#07

Selenium and Selenoproteins in Adipose Tissue Physiology and Obesity.

ReviewInfluence5.0
101
Researchers examined the relationship between selenium and obesity, finding inconsistent data on selenium status in obese individuals. They discussed the role of selenium in adipocyte metabolism but concluded that supplementation may not be effective for obesity prevention.
View on PubMed
#08

Serum selenium and non-alcoholic fatty liver disease (NAFLD) in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2011-2016.

HumanInfluence2.0
100
Researchers evaluated the relationship between serum selenium levels and non-alcoholic fatty liver disease (NAFLD) in U.S. adults. They found that higher selenium levels above approximately 130 μg/L were positively associated with increased serum alanine aminotransferase activity and NAFLD prevalence. No significant associations were observed below this selenium level.
View on PubMed
#09

Selenoproteins in nervous system development and function.

ReviewInfluence4.0
89
Researchers investigated the role of selenoproteins in brain development and function, linking selenium to oxidative stress defense. They noted that while selenium supplementation may benefit certain populations, definitive evidence for its use in common neurological conditions is lacking.
View on PubMed
#10

Selenium and thyroid diseases.

ReviewInfluence1.0
68
Researchers found a strong association between selenium and thyroid diseases, highlighting its role in thyroid hormone metabolism and cellular homeostasis. They observed that selenium supplementation may improve conditions like Graves' orbitopathy and Hashimoto's thyroiditis. However, the evidence regarding its anticancer activity in thyroid cancer remains conflicting.
View on PubMed

Clinical Trials (13)

13

Total Trials

1,055

Total Enrolled

Effects of a Legume-rich Diet in the Context of the Planetary Health Diet Compared to a Western-oriented Dietary Pattern in Participants with Increased Cardiometabolic Risk

NCT06700954NOT_YET_RECRUITING
Sponsor

University of Bonn

Enrollment

100

Started

2025

Primary outcome

Pameters of glucose metabolism in blood

Cardiovascular Diseases

The Effects of Yoga on Sensory, Motor, Cognitive Skills, and Perceived Stress in Children With Developmental Coordination Disorder

NCT07547514COMPLETED
Sponsor

Fenerbahce University

Enrollment

40

Started

2024

Primary outcome

The Bruininks-Oseretsky Motor Proficiency Test

Development Coordination DisorderMotor Coordination or Function; Developmental DisorderSensory Integration DisorderPerceived Stres LevelCognitive Ability General

Induction Chemotherapy Sequential Sintilimab Combined With Dual Epigenetic Drugs for ENKTL-HLH

NCT05008666Phase 2UNKNOWN
Sponsor

Sun Yat-sen University

Enrollment

37

Started

2021

Primary outcome

Objective response rate (ORR) after end of treatment

Safety and Efficacy

Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants

NCT01497431Phase 1COMPLETED
Sponsor

National Cancer Institute (NCI)

Enrollment

66

Started

2011

Primary outcome

Clinical toxicity of Se-methyl-seleno-L-cysteine according to the NCI CTCAE version 4.0

No Evidence of DiseaseProstate Carcinoma

Colon Cancer Prevention Using Selenium

NCT01211561Early Phase 1UNKNOWN
Sponsor

University of Illinois at Chicago

Enrollment

50

Started

2010

Primary outcome

Reduction in ACF biomarkers

Prevention of Colorectal Cancer

Influence of Selenium on Prostate Cancer Related Biomarkers

NCT01112449COMPLETED
Sponsor

Milton S. Hershey Medical Center

Enrollment

130

Started

2008

Primary outcome

Biomarkers of oxidative stress

Effect of Selenium on Oxidative Stress in Healthy Men

Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma

NCT00625183Phase 2TERMINATED
Sponsor

Roswell Park Cancer Institute

Enrollment

5

Started

2008

Primary outcome

Complete Pathological Response Rate

Colorectal Cancer

Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

NCT00526890Phase 2TERMINATED
Sponsor

Roswell Park Cancer Institute

Enrollment

16

Started

2006

Primary outcome

Incidence of Grade 3-4 Esophagitis

Lung Cancer

Selenium Supplementation of Patients With Cirrhosis

NCT00212212TERMINATED
Sponsor

Vanderbilt University

Enrollment

99

Started

2006

Primary outcome

Plasma selenium biomarkers

Cirrhosis

Selenium Supplementation of Patients With Cirrhosis

NCT00271245TERMINATED
Sponsor

Vanderbilt University

Enrollment

99

Started

2006

Primary outcome

Plasma selenoprotein P, Plasma GPX-3 activity, Total plasma selenium

Liver Disease

Predicting Dietary Selenium Needs to Achieve Target Blood Selenium Levels

NCT00803699COMPLETED
Sponsor

USDA Grand Forks Human Nutrition Research Center

Enrollment

262

Started

2005

Primary outcome

Evaluation of effectiveness of consuming oral doses of L-selenomethionine in raising plasma selenium concentrations

Nutritional Requirements

Selenium and Immune Function

NCT00279812COMPLETED
Sponsor

Quadram Institute Bioscience

Enrollment

133

Started

2005

Primary outcome

Cellular and Humoral Immune Response

Healthy

Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer

NCT00217516Phase 1COMPLETED
Sponsor

Roswell Park Cancer Institute

Enrollment

18

Started

2005

Primary outcome

Effects of selenium vs placebo on tissue biomarkers of prostate cancer susceptibility at 1 and 6 months after completion of study treatment

Prostate Cancer

Publication Trend

Research publications about Selen over time

10total
1
'01
1
'08
1
'11
1
'13
1
'18
1
'19
1
'20
1
'22
1
'23
1
'26

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer